BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6506297)

  • 1. [Medullary carcinoma of the thyroid].
    Olesen LL
    Ugeskr Laeger; 1984 Oct; 146(43):3260-4. PubMed ID: 6506297
    [No Abstract]   [Full Text] [Related]  

  • 2. Multidrug resistance gene and P-glycoprotein expression in anaplastic carcinoma of the thyroid.
    Yamashita T; Watanabe M; Onodera M; Shimaoka K; Ito K; Fujimoto Y; Itoyama S; Sugawara I
    Cancer Detect Prev; 1994; 18(5):407-13. PubMed ID: 7812988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of advanced medullary thyroid cancer with an alternating combination of doxorubicin-streptozocin and 5 FU-dacarbazine. Groupe d'Etude des Tumeurs à Calcitonine (GETC).
    Nocera M; Baudin E; Pellegriti G; Cailleux AF; Mechelany-Corone C; Schlumberger M
    Br J Cancer; 2000 Sep; 83(6):715-8. PubMed ID: 10952773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin receptor expression in vivo and response to somatostatin analog therapy with or without other antineoplastic treatments in advanced medullary thyroid carcinoma.
    Vainas I; Koussis Ch; Pazaitou-Panayiotou K; Drimonitis A; Chrisoulidou A; Iakovou I; Boudina M; Kaprara A; Maladaki A
    J Exp Clin Cancer Res; 2004 Dec; 23(4):549-59. PubMed ID: 15743023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated histaminase activity in medullary carcinoma of the thyroid gland.
    Baylin SB; Beaven MA; Engelman K; Sjoerdsma A
    N Engl J Med; 1970 Dec; 283(23):1239-44. PubMed ID: 4990961
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemosensitivity of anaplastic thyroid carcinoma and poorly differentiated thyroid carcinoma.
    Asakawa H; Kobayashi T; Komoike Y; Maruyama H; Nakano Y; Tamaki Y; Matsuzawa Y; Monden M
    Anticancer Res; 1997; 17(4A):2757-62. PubMed ID: 9252711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnostic and therapeutic aspects of medullary carcinoma of the thyroid].
    Collu L; Malloci A; Tarquini A; Meleddu G; Meleddu C; Massenti S
    Minerva Chir; 1983 Jul 15-31; 38(13-14):1075-9. PubMed ID: 6633893
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antitumor effect of UFT against differentiated thyroid cancer].
    Suzumura K; Koike A; Naruse T; Matsumoto K; Nagata H; Kojima T; Kanemitsu T; Katoh K
    Gan To Kagaku Ryoho; 1994 Oct; 21(14):2485-9. PubMed ID: 7944495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of galectin 3 expression in thyroid aspirates as a diagnostic marker in differentiating benign from malignant thyroid neoplasms.
    Aron M; Kapila K; Verma K
    Indian J Pathol Microbiol; 2006 Jul; 49(3):376-80. PubMed ID: 17001889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy of stage IV B anaplastic thyroid carcinoma: single institution experience.
    Vrbic S; Pejcic I; Vrbic M; Filipovic S
    J BUON; 2009; 14(1):41-4. PubMed ID: 19373945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Medullary carcinoma of the thyroid--epidemiologic, diagnostic and therapeutic aspects].
    Groth P; Bartelt B; Schwähn D; Reincke R
    Radiobiol Radiother (Berl); 1987; 28(2):191-4. PubMed ID: 3659307
    [No Abstract]   [Full Text] [Related]  

  • 12. Glycerol enhances CDDP-induced growth inhibition of thyroid anaplastic carcinoma tumor carrying mutated p53 gene.
    Yuki K; Takahashi A; Ota I; Ohnishi K; Yasumoto J; Kanata H; Yane K; Hosoi H; Ohnishi T
    Oncol Rep; 2004 Apr; 11(4):821-4. PubMed ID: 15010879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histaminase and medullary thyroid carcinoma.
    Melvin KE
    N Engl J Med; 1970 Dec; 283(23):1286-7. PubMed ID: 4990962
    [No Abstract]   [Full Text] [Related]  

  • 14. Two cases of thyroid carcinoma producing granulocyte colony-stimulating factor.
    Kitanishi T; Suzuki M; Fukui J; Taniguchi K; Kitano H; Yazawa Y; Kitajima K
    J Otolaryngol; 2000 Jun; 29(3):174-8. PubMed ID: 10883833
    [No Abstract]   [Full Text] [Related]  

  • 15. [The importance of titrating immunoreactive calcitonin in medullary carcinoma of the thyroid gland].
    Neradilová M; Nĕmec J; Soutorová M; Bednár J
    Rozhl Chir; 1987 Feb; 66(2):114-8. PubMed ID: 3563716
    [No Abstract]   [Full Text] [Related]  

  • 16. [Diagnostic value of determination of blood histaminase in medullary carcinoma of the thyroid gland].
    Wasylewski A; Skrzypek J; Bartoszewska J; Chorazy M
    Pol Tyg Lek; 1979 Aug; 34(34):1341-3. PubMed ID: 116203
    [No Abstract]   [Full Text] [Related]  

  • 17. Medullary thyroid cancer--diagnosis and active screening.
    Neradilova M; Nĕmec J; Soutorova M
    Radiobiol Radiother (Berl); 1987; 28(5):719-22. PubMed ID: 3441638
    [No Abstract]   [Full Text] [Related]  

  • 18. Combining provocative agents of calcitonin to detect medullary carcinoma of the thyroid.
    Sisson JC; Gross MD; Frietas JE; Jackson CE; England BG
    Henry Ford Hosp Med J; 1981; 29(2):75-80. PubMed ID: 7263287
    [No Abstract]   [Full Text] [Related]  

  • 19. Medullary carcinoma of the thyroid.
    J Assoc Physicians India; 1977 Apr; 25(4):289-91. PubMed ID: 914760
    [No Abstract]   [Full Text] [Related]  

  • 20. Thyroid diffuse large B cell lymphoma (DLBCL) following thyroid medullary cancer: long-term complete remission with R-CHOP therapy.
    Dai CW; Zhang GS; Pei MF; Shen JK
    Ann Hematol; 2009 Jul; 88(7):701-2. PubMed ID: 19015853
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.